Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 15;6(4):535-41.
doi: 10.1021/acschemneuro.5b00055. Epub 2015 Mar 24.

PET neuroimaging studies of [(18)F]CABS13 in a double transgenic mouse model of Alzheimer's disease and nonhuman primates

Affiliations

PET neuroimaging studies of [(18)F]CABS13 in a double transgenic mouse model of Alzheimer's disease and nonhuman primates

Steven H Liang et al. ACS Chem Neurosci. .

Abstract

Fluorine-18 labeled 2-fluoro-8-hydroxyquinoline ([(18)F]CABS13) is a promising positron emission tomography (PET) radiopharmaceutical based on a metal chelator developed to probe the "metal hypothesis of Alzheimer's disease". Herein, a practical radiosynthesis of [(18)F]CABS13 was achieved by radiofluorination followed by deprotection of an O-benzyloxymethyl group. Automated production and formulation of [(18)F]CABS13 resulted in 19 ± 5% uncorrected radiochemical yield, relative to starting [(18)F]fluoride, with ≥95% chemical and radiochemical purities, and high specific activity (>2.5 Ci/μmol) within 80 min. Temporal PET neuroimaging studies were carried out in female transgenic B6C3-Tg(APPswe,PSEN 1dE9)85Dbo/J (APP/PS1) and age-matched wild-type (WT) B6C3F1/J control mice at 3, 7, and 10 months of age. [(18)F]CABS13 showed an overall higher uptake and retention of radioactivity in the central nervous system of APP/PS1 mice versus WT mice with increasing age. However, PET/magnetic resonance imaging in normal nonhuman primates revealed that the tracer had low uptake in the brain and rapid formation of a hydrophilic radiometabolite. Identification of more metabolically stable (18)F-hydroxyquinolines that can be readily accessed by the radiochemical strategy presented herein is underway.

Keywords: APP/PS1; [18F]CABS13; metal hypothesis of Alzheimer’s disease; nonhuman primates; rodents; transgenic mice.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Longitudinal PET studies in APP/PS1 transgenic mice of AD versus wild-type controls. (A) PET images (axial, coronal and sagittal) summed at 5-10 min post-injection of 10 month-old transgenic mice (left) versus WT controls (right); (B) Time-activity curves and (C) AUC measurement in whole brain between transgenic mice of AD versus WT controls in 3, 7 and 10 months.
Figure 2
Figure 2
Summed PET (0-15 min) with structural MR images (top). Radioactivity is seen primarily in the confluence of the sinuses (torcula) with the highest intensity just inside the occipital protuberance (lower left). Time-activity curve for the radioactivity observed is also shown (bottom right).
Scheme 1
Scheme 1
Improved radiosynthesis of [18F]CABS13 based on benzyloxymethyl precursor 1. (A) Reaction conditions and radiosynthesis results. (B) Plausible mechanism of trifluoroacetic acid mediated deprotection and formation of side products under aqueous acidic conditions.

Similar articles

Cited by

References

    1. Zhu L, Ploessl K, Kung HF. PET/SPECT imaging agents for neurodegenerative diseases. Chem. Soc. Rev. 2014;43:6683–6691. - PMC - PubMed
    1. McConathy J, Sheline YI. Imaging Biomarkers Associated With Cognitive Decline: A Review. Biol. Psychiatry - PMC - PubMed
    1. Kepe V, Moghbel MC, Langstrom B, Zaidi H, Vinters HV, Huang S-C, Satyamurthy N, Doudet D, Mishani E, Cohen RM, Hoilund-Carlsen PF, Alavi A, Barrio JR. Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review. J. Alzheimers Dis. 2013;36:613–631. - PMC - PubMed
    1. Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. The Lancet Neurology. 2013;12:357–367. - PubMed
    1. Holland JP, Liang SH, Rotstein BH, Collier TL, Stephenson NA, Greguric I, Vasdev N. Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque. J. Labelled. Compd. Radiopharm. 2014;57:323–331. - PubMed

Publication types

MeSH terms